US Patent Issued to REGENERON PHARMACEUTICALS on March 3 for "Protein-antiviral compound conjugates" (New York Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,640, issued on March 3, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Protein-antiviral compound conjugates" was invented by Alina Baum (Pleasantville, N.Y.) and Thomas Nittoli (Pearl River, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds, compositions, and methods for the treatment of diseases and disorders associated with influenza, including VX-787 and derivatives thereof, baloxavir and derivatives thereof, and baloxavir marboxil and derivatives thereof, and protein (e.g., antibody) drug conjugates thereof."

The patent was filed on July 24, 2023, under Application No. 18/225,567.

*For furth...